The U.S. Department of Health and Human Services is buying up to 1.25 million more doses of Regeneron’s Covid-19 antibody therapy, for $2.63 billion. . . . → Read More: US Govt to Buy 1.25M Regeneron Covid-19 Therapies
|
|||||
|
       
  |
A current Covid-19 vaccine is shown in lab tests to produce antibodies that appear to protect against new mutations found in South Africa and the U.K. . . . → Read More: Vaccine Shown Active Against New Covid-19 Variants 
The U.S. Food and Drug Administration issued draft administrative and procedural guidelines for genetic disorders treated with precise gene therapies. . . . → Read More: FDA Issues Precision Genomic Drug Guidance  Comments are closed  Regulations  biomedical, biotechnology, clinical trials, FDA, genomics, life sciences, pharmaceuticals, preclinical, university 
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, genomics, life sciences, manufacturing, pharmaceuticals, stem cells, university 
Findings from a clinical trial show a wearable device sending electronic signals into the nervous system relieves migraine pain in children age 12 to 17. . . . → Read More: Neuro Device Shown to Relieve Adolescent Migraine Pain Comments are closed New products biomedical, clinical trials, engineering, FDA, Israel, life sciences, medical device, software 
A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO One comment - (Comments are closed) Finance biomedical, biotechnology, Canada, clinical trials, Covid-19, equity, FDA, investment, IPO, NIH, pharmaceuticals 
The Food and Drug Administration began a pilot program for assessing alternative technologies to test drugs, biologics, and devices without animals. . . . → Read More: FDA Begins Qualifying Non-Animal Testing Options Comments are closed Regulations biomedical, engineering, FDA, life sciences, medical device, pharmaceuticals, preclinical 
Researchers at University of Pennsylvania and Regeneron are studying delivery of synthetic antibodies directly to the nose to prevent Covid-19 infections. . . . → Read More: Univ, Industry Labs Study Inhaled Covid-19 Antibodies One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, biotechnology, Covid-19, FDA, life sciences, pharmaceuticals, preclinical, university 
Makers of a Covid-19 vaccine given as a nasal spray asked the Food and Drug Administration to authorize a a human clinical trial of the vaccine. . . . → Read More: Trial Requested for Covid-19 Vaccine Nasal Spray 3 comments - (Comments are closed) Joint ventures/collaborations, New products, Regulations biomedical, clinical trials, Covid-19, FDA, life sciences, medical device, pharmaceuticals, preclinical, university 
Global drug maker Novartis is acquiring a stem cell-based treatment for a serious respiratory disease associated with Covid-19 infections. . . . → Read More: Stem Cell Respiratory Therapy Licensed in $1.4B Deal Comments are closed Intellectual property, Joint ventures/collaborations Australia, biomedical, biotechnology, clinical trials, Covid-19, equity, Europe, FDA, investment, licensing, life sciences, manufacturing, pharmaceuticals, stem cells |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||